FDA adviser who resigned over Alzheimer’s drug says ‘no good evidence’ it works
One of the FDA advisory panel members who resigned after the agency granted Biogen’s Alzheimer’s drug Accelerated Approval has said “the drug showed no good evidence that it worked.”